Jack Ma Foundation and Alibaba Foundation shares Handbook of COVID-19 Prevention and Treatment

Food and Healthcare Press Releases Wednesday March 18, 2020 16:15
Bangkok--18 Mar--124 Communications Consulting

The Jack Ma Foundation and Alibaba Foundation are today sharing some key lessons and experience from doctors and other medical administrators and staff at the First Affiliated Hospital, Zhejiang University School of Medicine (FAHZU), who were at the frontline of COVID-19 treatment in China and crucial to slowing its spread.

In the form of a digital handbook, the medical administrators and staff cover and share globally what they’ve learned every step of the way, from screening, to diagnosis and treatment of patients who contracted COVID-19.

Over a 50-day period, FAHZU admitted 104 patients confirmed ill with COVID-19, including 78 critically ill patients. Through pioneering efforts of medical staff and investment in new technologies, FAHZU has so far made it through the public health crisis without a single medical staff infection, missed diagnosis or patient death.

It is the hope of the Jack Ma Foundation and the Alibaba Foundation that medical administrators and staff around the world find this handbook helpful and useful in treating COVID-19 patients.

“Today, with the spread of the global pandemic, these experiences are precious and the most-important weapon for medical personnel,” wrote Jack Ma in a foreword in the handbook.   “We hope that, with this handbook, doctors and nurses in other affected areas can learn from experience as they face this battle, without having to start from scratch.”

Medical administrators and staff can download the handbook at covid-19.alibabacloud.com.
Follow Jack Ma and Jack Ma Foundation on Twitter for the Foundation’s latest efforts to combat COVID-19. Please contact us with further questions.

Latest Press Release

Ansell Urges Global Priority For Supply Of Personal Protective Equipment

Ansell Limited, a global leader in protective solutions, is working with governments and health organizations worldwide to ensure unrestricted personal protective equipment (PPE) manufacture and supply is given top priority during the COVID-19...

Yiling Pharmacy Lianhua Qingwen has been approved by the Thai FDA

On March 31, Shijiazhuang Yiling Pharmaceutical Co., Ltd released a notice that they had received the approval of the modern herbal medicine registration issued by the Food and Drug Administration of Thailand. Lianhua Qingwen Capsule is recognized as in...

EW Nutrition Launches Industry-leading Webinar Series With Topical Antimicrobial Resistance Twin Sessions

Yesterday, German-based company EW Nutrition took a first step toward serving the animal production industry in these challenging times. The in-feed and on-farm solutions company has started a series of topical webinars on challenging issues such as...

Saxenda(R) Demonstrated Improvements in BMI and Body Weight in Adolescents With Obesity

Novo Nordisk today announced that the New England Journal of Medicine published results of a phase 3 trial evaluating the investigational use of Saxenda(R) (liraglutide 3.0 mg) in adolescents (aged 12–<18) with obesity.1 The study was accepted...

Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use

Johnson & Johnson and BARDA Together Commit More than $1 Billion to Novel Coronavirus Vaccine Research and Development; Company Expects to Initiate Phase 1 Human Clinical Studies of Vaccine Candidate at Latest by September 2020 Johnson & Johnson...

Related Topics